IOBT
IO Biotech
IOBT
IOBT
Delisted
IOBT was delisted on the 6th of April, 2026.
18 hedge funds and large institutions have $47.4M invested in IO Biotech in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $59.6M → $47.4M (-$12.1M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
18
Holding in Top 10
1
Calls
$1.71M
Puts
–
Top Buyers
| 1 | +$546K | |
| 2 | +$136K | |
| 3 | +$78.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$27.6K |
Top Sellers
| 1 | -$4.11M | |
| 2 | -$2.62M | |
| 3 | -$1.14M | |
| 4 |
AC
Armistice Capital
New York
|
-$347K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$35.7K |